Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : U.S. CDC Says 183,670,870 Individuals Have Been Fully Vaccinated Against COVID-19 As Of Sept 26

09/26/2021 | 03:22pm EDT

Sept 26 (Reuters) - U.S. Centers for Disease Control and Prevention:

* U.S. CDC SAYS 183,670,870 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF SEPT 26 VERSUS 183,353,326 INDIVIDUALS AS OF SEPT 25

* U.S. CDC SAYS 213,456,787 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF SEPT 26 VERSUS 213,177,462 INDIVIDUALS AS OF SEPT 25

* U.S. CDC SAYS ADMINISTERED 390,114,328 DOSES OF COVID-19 VACCINE AS OF SEPT 26 VERSUS 389,372,689 DOSES ADMINISTERED AS OF SEPT 25

* U.S. CDC SAYS 2.66 MILLION PEOPLE RECEIVED AN ADDITIONAL COVID-19 VACCINE DOSE SINCE AUGUST 13, 2021

* U.S. CDC SAYS DELIVERED 471,814,235 DOSES OF COVID-19 VACCINE AS OF SEPT 26 Further company coverage:


ę Reuters 2021
All news about MODERNA, INC.
05:20pU.S. administers over 415 mln doses of COVID-19 vaccines - CDC
RE
02:39pModerna Announces First Participant Dosed in Phase 3 Pivotal Registration Study of Its ..
BU
11:56aSwitzerland Agency Approves Moderna and Pfizer/BioNTech Boosters
DJ
11:40aModerna Wins Swiss Regulator's Approval For Booster Dose of COVID-19 Vaccine
MT
11:31aModerna Signs MoU With African Union to Supply Up to 110 Million COVID-19 Vaccine Doses
MT
11:23aCOVID-19 vaccines safe for people with history of severe allergies, study finds
AQ
11:10aSWITZERLAND APPROVES MODERNA COVID B : Bloomberg
MT
10:13aModerna Secures Swiss Regulator's Approval For Booster Dose of COVID-19 Vaccine
MT
09:45aModerna Announces Swissmedic Authorizes Booster Dose of Moderna's COVID-19 Vaccine
BU
09:17aHealth Care Stocks Edge Higher Premarket Tuesday
MT
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 20 374 M - -
Net income 2021 12 558 M - -
Net cash 2021 13 559 M - -
P/E ratio 2021 11,6x
Yield 2021 -
Capitalization 140 B 140 B -
EV / Sales 2021 6,18x
EV / Sales 2022 5,47x
Nbr of Employees 1 300
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Last Close Price 345,74 $
Average target price 295,79 $
Spread / Average Target -14,4%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.234.60%141 099
LONZA GROUP AG31.93%60 646
IQVIA HOLDINGS INC.43.58%49 145
SEAGEN INC.0.22%31 933
CELLTRION, INC.-38.02%25 328
ALNYLAM PHARMACEUTICALS, INC.53.63%23 730